Comments on: “Trading costs on the Stock Exchange of Thailand” Authors: Charoenwong C., Ding D.K., Jenwittayaroje N. Comments on: “Risk-taking behaviour during downturn: evidence of loss-chasing and

President The Stock Exchange of Thailand Aapico Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 3rd quarter of fiscal year 2022

Hero Experience Company Limited on Shareholding Proportion To: President The Stock Exchange of Thailand According to the fact that Demeter Corporation Public Company Limited (the “Company”) has invested

Hero Experience Company Limited on Shareholding Proportion (Revised) To: President The Stock Exchange of Thailand According to the fact that Demeter Corporation Public Company Limited (the “Company”) has

Microsoft Word - MDA Q219 EN August 14, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent

contribute high gross margin; 4) marketing activities to help dry stock at trade stores and prepare for new packaging launch in Q3; and 5) increased administrative expenses from higher personnel expenses to

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3

No: AH 02022023 February 28th, 2023 Subject: Management Discussion & Analysis (MD&A) for the financial statements of fiscal year 2022 ended as of December 31, 2022 To: The President The Stock Exchange

1 27 May 2019 Subject: Explanation of operating result in the financial statement ended 31 March 2019 To: President of the Stock Exchange of Thailand With reference to the financial statement of FY